Skip to content

Lemon Verbena Extract Oxidative Stress and Muscle Damage

Evaluation of the Efficacy of Supplementation With Lemon Verbena Extract in Improving

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04742244
Enrollment
60
Registered
2021-02-08
Start date
2020-05-28
Completion date
2020-08-13
Last updated
2021-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Injury, Muscle Soreness

Keywords

DOMS,, Lemon verbena

Brief summary

In the present study, investigators investigated whether supplementation with lemon verbena extract (LVE) could improve muscle damage and biochemical indicators after exhaustive exercise challenge. Based on maximum jump heights, 60 subjects (30 males and 30 females) were equally divided into a placebo group (0 mg/human/day) and an LVE supplement group (400 mg/human/day), with gender-equal distribution. All subjects started supplementation 10 days before exhaustive exercise and continued it until all tests were completed. Before the intervention, after the exhaustive exercise, and on the following 3 days, the participants underwent 12-minute Cooper running/walking; blood collection; assessments of pain, muscle stiffness, maximum jump heights, and isometric maximum muscle strength; and anaerobic strength tests.

Interventions

DIETARY_SUPPLEMENTLvemon verbena extract

Each capsule contained 200 mg of lemon verbena extract 2 capsules/day, 14 days

DIETARY_SUPPLEMENTmaltodextrin

Each capsule contained 0 mg of lemon verbena extract 2 capsules/day, 14 days

Sponsors

National Taiwan Sport University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* health * Must be able to swallow tablets

Exclusion criteria

* non-smokers * no musculoskeletal * medical * metabolic disease * women not on the reproductive cycle * high blood pressure, asthma * skeletal neuromuscular injuries in the upper or lower extremities

Design outcomes

Primary

MeasureTime frameDescription
inflammation of IL-6 level10 daysTo assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, including baseline (0) and 3h, 24h, and 48 after exercise, blood samples were collected with brachial venous catheters. Assess serum IL-6 levels (pg/ml) to monitor physiological fitness. Used commercial kit human IL-6 immunoassay (R&D system, Minnesota, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis
Clinical Biochemistry of CK level10 daysTo assess muscle damage, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, including baseline (0) and 3h, 24h, and 48 after exercise, blood samples were collected with brachial venous catheters. Serum CK (U/L), were assessed for monitoring physiological adaptation. All biochemical indices were assessed using an autoanalyzer (Hitachi 7060, Tokyo, Japan).
Stress hormones 8-Hydroxy-2'-Deoxyguanosine (8-OHdG) in Urine10 daysSubjects' urine was collected 24 hours after the exhaustive exercise for analysis. Used commercial kit human 8-OHdG (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis
Assessment of muscle stiffness10 days3 h, 24h, 48h after exhausting exercise, use Myoton machine to evaluate muscle stiffness (N/m) (Myoton, Tallinn, Estonia)
Visual Analogue Scale (VAS) evaluation10 days3 h, 24h, 48h after exhausting exercise, use VAS questionnaire to record muscle pain. the minimum is 0 and maximum is 10, and whether higher scores mean more pain

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026